Former FDA Chiefs Call For CMS Demo On Drug Value-Based Pay

Three former FDA commissioners are calling for CMS to test using data from multiple sources to gauge outcomes of value-based pay models for high-cost drugs and biologics. The demonstration would rely on clinical, administrative and patient-generated data. The proposal is in line with the Trump administration’s American Patients First Blueprint, which calls for testing whether value-based payment models control drugs costs. CMS also recently requested public input on how its innovation center could improve data interoperability by testing innovative payment...